Kiniksa Pharmaceuticals International KNSA
NASDAQ KNSA
$74.66 -1.07 (-1.41%)
As of: Sep 30, 2026 · 12:24 PM EDT

Kiniksa Pharmaceuticals International, plc (KNSA) EV to EBITDA (2022 - 2026)

Updated

Kiniksa Pharmaceuticals International's (KNSA) EV to EBITDA stood at 92.61 in Q2 2026, down 85.4% from 634.31 a year earlier but up 26.8% from the prior quarter.

Analysis

Kiniksa Pharmaceuticals International, plc (KNSA) EV to EBITDA (2022 - 2026) Analysis & Trends

On a TTM basis, Kiniksa Pharmaceuticals International's EV to EBITDA came in at 85.41 as of Jun 30, 2026, down 86.5% year-over-year; for FY2025, it was 74.77.

  • Across earlier years, EV to EBITDA came in at 155.92 in FY2022.
  • Quarterly EV to EBITDA has ranged from 44.33 in Q2 2023 to 634.31 in Q2 2025 over the past five years.
  • Per Business Quant, the preceding three quarters came in at 73.02 (Q1 2026), 74.77 (Q4 2025) and 139.61 (Q3 2025).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 92.61
Mar 31, 2026 73.02
Dec 31, 2025 74.77
Sep 30, 2025 139.61
Jun 30, 2025 634.31
Jun 30, 2023 44.33
Mar 31, 2023 54.30
Dec 31, 2022 155.92
API Access

Kiniksa Pharmaceuticals International, plc EV to EBITDA API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=KNSA&period=max&api_key=YOUR_API_KEY